益生菌和后生元制剂在化妆品和女性私护品中应用的机遇与挑战
Opportunities and Challenges of Application of the Probiotics/Postbiotics in Cosmetics and Female Personal Care Products
摘要: 益生菌是能够给与宿主带来健康益处的活菌；而后生元是益生菌细胞膜的组成成份及其次级代谢产物的提取物，包含多种酶类、短链脂肪酸、维生素、氨基酸、脂多糖和磷壁酸等物质。益生菌/后生元相关产品在市场上越来越受到人们的青睐和关注。然而，目前市场上大多数益生菌/后生元的产品是不符合其定义标准的。近年来，化妆品产业已经出现了大量号称为益生菌/后生元的产品。这些益生菌/后生元制剂在个人护理产品中有多种潜在应用价值，特别是口腔、皮肤和私密护理产品，但仍需要对这些产品的标签和营销标准进行必要的监管，以确保消费者能正确的购买相关产品。本文综述了益生菌/后生元在个人护理行业的市场、监管和潜在应用。
Abstract: Probiotics, defined as “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host,” are becoming increasingly popular and marketable. Postbiotics are the extracts of cell membrane components and secondary metabolites of non-viable probiotics, such as enzymes, short chain fatty acids, vitamins, amino acids, peptides, surface proteins, teichoic acids, lipopolysaccharides, etc. However, too many of the products currently labelled as probiotics fail to comply with the defining characteristics. In recent years, the cosmetic industry has increased the number of products classified as probiotics. While there are several potential applications for probiotics in personal care products, specifically for oral, skin, and intimate care, proper regulation of the labelling and marketing standards is still required to guarantee that consumers are indeed purchasing a probiotic product. This review explores the current market, regulatory aspects, and potential applications of probiotics in the personal care industry.
文章引用：李冠楠, 王海玲, 王小咪, 孙海月, 王小兰, 黄生权. 益生菌和后生元制剂在化妆品和女性私护品中应用的机遇与挑战[J]. 微生物前沿, 2023, 12(1): 1-9. https://doi.org/10.12677/AMB.2023.121001

参考文献

[1] 刘颖, 张欢, 牛超杰, 袁阳华, 常超. 后生元的开发与应用研究新趋势[J]. 武汉轻工大学学报, 2021, 40(5): 14-20, 60.
[2] Puebla-Barragan, S. and Reid, G. (2021) Probiotics in Cosmetic and Personal Care Products: Trends and Challenges. Molecules, 26, Article No. 1249. [Google Scholar] [CrossRef] [PubMed]
[3] Nakatsuji, T., Chiang, H.-I., Jiang, S.B., Nagarajan, H., Zengler, K. and Gallo, R.L. (2013) The Microbiome Extends to Subepidermal Compartments of Normal Skin. Nature Communications, 4, Article No. 1431. [Google Scholar] [CrossRef] [PubMed]
[4] Matts, P.J. (2008) New Insights into Skin Appearance and Measurement. Journal of Investigative Dermatology Symposium Proceedings, 13, 6-9. [Google Scholar] [CrossRef] [PubMed]
[5] Guéniche, A., Bastien, P., Ovigne, J.M., Kermici, M., Courchay, G., Chevalier, V., Breton, L. and Castiel-Higounenc, I. (2010) Bifidobacterium longum Lysate, a New Ingredient for Reactive Skin. Experimental Dermatology, 19, e1-e8. [Google Scholar] [CrossRef] [PubMed]
[6] Klein, G., Schanstra, J.P., Hoffmann, J., Mischak, H., Siwy, J. and Zimmermann, K. (2013) Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products. PLoS One, 8, e66682. [Google Scholar] [CrossRef] [PubMed]
[7] Villa, E., Garelli, V., Braido, F., Melioli, G. and Canonica, G.W. (2010) May We Strengthen the Human Natural Defenses with Bacterial Lysates? World Allergy Organization Journal, 3, S17-S23. [Google Scholar] [CrossRef] 
[8] Sultana, R., McBain, A.J. and O’Neill, C.A. (2013) Strain-Dependent Augmentation of Tight-Junction Barrier Function in Human Primary Epidermal Keratinocytes by Lactobacillus and Bifidobacterium Lysates. Applied and Environmental Microbiology, 79, 4887-4894. [Google Scholar] [CrossRef] 
[9] Mokrozub, V.V., Lazarenko, L.M., Sichel, L.M., Babenko, L.P., Lytvyn, P.M., Demchenko, O.M., Melnichenko, Y.O., Boyko, N.V., Biavati, B., Digioia, D., et al. (2015) The Role of Beneficial Bacteria Wall Elasticity in Regulating Innate Immune Response. EPMA Journal, 6, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[10] Mohammedsaeed, W., Cruickshank, S., McBain, A.J. and O’Neill, C.A. (2015) Lactobacillus rhamnosus GG Lysate Increases Re-Epithelialization of Keratinocyte Scratch Assays by Promoting Migration. Scientific Reports, 5, Article No. 16147. [Google Scholar] [CrossRef] [PubMed]
[11] Ankrah, N.Y.D., May, A.L., Middleton, J.L., Jones, D.R., Hadden, M.K., Gooding, J.R., LeCleir, G.R., Wilhelm, S.W., Campagna, S.R. and Buchan, A. (2014) Phage Infection of an Environmentally Relevant Marine Bacterium Alters Host Metabolism and Lysate Composition. The ISME Journal, 8, 1089-1100. [Google Scholar] [CrossRef] [PubMed]
[12] Genova, E., Pelin, M., Decorti, G., Stocco, G., Sergo, V., Ventura, A. and Bonifacio, A. (2018) SERS of Cells: What Can We Learn from Cell Lysates? Analytica Chimica Acta, 1005, 93-100. [Google Scholar] [CrossRef] [PubMed]
[13] Navarro-López, V., Martínez-Andrés, A., Ramírez-Boscá, A., Ruzafa-Costas, B., Núñez-Delegido, E., Carrión-Gutiérrez, M.A., Prieto-Merino, D., Codoñer-Cortés, F., Ramón-Vidal, D., Genovés-Martínez, S., et al. (2019) Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: A Randomized Controlled Clinical Trial. Acta Dermato-Venereologica, 99, 1078-1084. [Google Scholar] [CrossRef] [PubMed]
[14] Yu, Y., Dunaway, S., Champer, J., Kim, J. and Alikhan, A. (2020) Changing Our Microbiome: Probiotics in Dermatology. British Journal of Dermatology, 182, 39-46. [Google Scholar] [CrossRef] 
[15] Korpela, K., Salonen, A., Vepsäläinen, O., Suomalainen, M., Kolmeder, C., Varjosalo, M., Miettinen, S., Kukkonen, K., Savilahti, E., Kuitunen, M., et al. (2018) Probiotic Supplementation Restores Normal Microbiota Composition and Function in Antibiotic-Treated and in Caesarian-Born Infants. Microbiome, 6, Article No. 182. [Google Scholar] [CrossRef] [PubMed]
[16] Sharma, D., Kober, M.-M. and Bowe, W.P. (2016) Anti-Aging Effects of Probiotics. Journal of Drugs in Dermatology, 15, 9-12.
[17] Jung, G.W., Tse, J.E., Guiha, I. and Rao, J. (2013) Prospective, Randomized, Open-Label Trial Comparing the Safety, Efficacy, and Tolerability of an Acne Treatment Regimen with and without a Probiotic Supplement and Minocycline in Subjects with Mild to Moderate acne. Journal of Cutaneous Medicine and Surgery, 17, 114-122. [Google Scholar] [CrossRef] [PubMed]
[18] Knackstedt, R., Knackstedt, T. and Gatherwright, J. (2020) The Role of Topical Probiotics in Skin Conditions: A Systematic Review of Animal and Human Studies and Implications for Future Therapies. Experimental Dermatology, 29, 15-21. [Google Scholar] [CrossRef] [PubMed]
[19] Kalliomäki, M., Salminen, S., Poussa, T., Arvilommi, H. and Isolauri, E. (2003) Probiotics and Prevention of Atopic Disease: 4-Year Follow-up of a Randomized Placebo-Controlled Trial. Lancet, 361, 1869-1871. [Google Scholar] [CrossRef] 
[20] Isolauri, E., Kalliomaki, M., Laitinen, K. and Salminen, S. (2008) Modulation of the Maturing Gut Barrier and Microbiota: A Novel Target in Allergic Disease. Current Pharmaceutical Design, 14, 1368-1375. [Google Scholar] [CrossRef] [PubMed]
[21] Hubálek, Z. (2003) Protectants Used in the Cryopreservation of Microorganisms. Cryobiology, 46, 205-229. [Google Scholar] [CrossRef] 
[22] Yao, M., Xie, J., Du, H., McClements, D.J., Xiao, H. and Li, L. (2020) Progress in Microencapsulation of Probiotics: A Review. Comprehensive Reviews in Food Science and Food Safety, 19, 857-874. [Google Scholar] [CrossRef] [PubMed]
[23] Puebla-Barragan, S. and Reid, G. (2019) Forty-Five-Year Evolution of Probiotic Therapy. Microbial Cell, 6, 184-196. [Google Scholar] [CrossRef] [PubMed]
[24] Bruce, A.W., Chadwick, P., Hassan, A. and VanCott, G.F. (1973) Recurrent Urethritis in Women. Canadian Medical Association Journal, 108, 973-976.
[25] Kale, V.V., Trivedi, R.V., Wate, S.P. and Bhusari, K.P. (2005) Development and Evaluation of a Suppository Formulation Containing Lactobacillus and Its Application in Vaginal Diseases. Annals of the New York Academy Science, 1056, 359-365. [Google Scholar] [CrossRef] [PubMed]
[26] Bruce, A.W. and Reid, G. (1988) Intravaginal Instillation of Lactobacilli for Prevention of Recurrent Urinary Tract Infections. Canadian Journal of Microbiology, 34, 339-343. [Google Scholar] [CrossRef] [PubMed]
[27] Reid, G., Bruce, A.W., Fraser, N., Heinemann, C., Owen, J. and Henning, B. (2001) Oral Probiotics Can Resolve Urogenital Infections. FEMS Immunology & Medical Microbiology, 30, 49-52. [Google Scholar] [CrossRef] 
[28] Stapleton, A.E., Au-Yeung, M., Hooton, T.M., Fredricks, D.N., Roberts, P.L., Czaja, C.A., Yarova-Yarovaya, Y., Fiedler, T., Cox, M. and Stamm, W.E. (2011) Randomized, Placebo-Controlled Phase 2 Trial of a Lactobacillus crispatus Probiotic Given Intravaginally for Prevention of Recurrent Urinary Tract Infection. Clinical Infectious Diseases, 52, 1212-1217. [Google Scholar] [CrossRef] [PubMed]
[29] Verdenelli, M.C., Cecchini, C., Coman, M.M., Silvi, S., Orpianesi, C., Coata, G., Cresci, A. and Di Renzo, G.C. (2016) Impact of Probiotic SYNBIO® Administered by Vaginal Suppositories in Promoting Vaginal Health of Apparently Healthy Women. Current Microbiology, 73, 483-490. [Google Scholar] [CrossRef] [PubMed]
[30] Rossi, A., Rossi, T., Bertini, M. and Caccia, G. (2010) The Use of Lactobacillus rhamnosus in the Therapy of Bacterial Vaginosis. Evaluation of Clinical Efficacy in a Population of 40 Women Treated for 24 Months. Archives of Gynecology and Obstetrics, 281, 1065-1069. [Google Scholar] [CrossRef] [PubMed]
[31] Petricevic, L. and Witt, A. (2008) The Role of Lactobacillus caseirhamnosus Lcr35 in Restoring the Normal Vaginal Flora after Antibiotic Treatment of Bacterial Vaginosis. BJOG: An International Journal of Obstetrics & Gynaecology, 115, 1369-1374. [Google Scholar] [CrossRef] [PubMed]
[32] Larsson, P.G., Brandsborg, E., Forsum, U., Pendharkar, S., Andersen, K.K., Nasic, S., Hammarström, L. and Marcotte, H. (2011) Extended Antimicrobial Treatment of Bacterial Vaginosis Combined with Human Lactobacilli to Find the Best Treatment and Minimize the Risk of Relapses. BMC Infectious Diseases, 11, Article No. 223. [Google Scholar] [CrossRef] [PubMed]
[33] Anukam, K., Osazuwa, E., Ahonkhai, I., Ngwu, M., Osemene, G., Bruce, A.W. and Reid, G. (2006) Augmentation of Antimicrobial Metronidazole Therapy of Bacterial Vaginosis with Oral Probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: Randomized, Double-Blind, Placebo-Controlled Trial. Microbes and Infection, 8, 1450- 1454. [Google Scholar] [CrossRef] [PubMed]
[34] Martinez, R.C.R., Franceschini, S.A., Patta, M.C., Quintana, S.M., Candido, R.C., Ferreira, J.C., De Martinis, E.C.P. and Reid, G. (2009) Improved Treatment of Vulvovaginal Candidiasis with Fluconazole Plus Probiotic Lactobacillus rhanosus GR-1 and Lactobacillus reuteri RC-14. Letters in Applied Microbiology, 48, 269-274. [Google Scholar] [CrossRef] 
[35] Vujic, G., Knez, A.J., Stefanovic, V.D. and Vrbanovic, V.K. (2013) Efficacy of Orally Applied Probiotic Capsules for Bacterial Vaginosis and Other Vaginal Infections: A Double-Blind, Randomized, Placebo-Controlled Study. European Journal of Obstetrics & Gynecology and Reproductive Biology, 168, 75-79. [Google Scholar] [CrossRef] [PubMed]
[36] 何红鹏, 李伟强, 高歌, 赵蕾, 郭昌林, 刘浩成. 阴道益生菌制剂在女性生殖道疾病治疗中的应用研究概述[J]. 天津科技大学学报, 2021, 36(6): 75-80.
[37] Sauperl, O., Zabret, A. and Zemljič, L.F. (2020) Development of Advanced Sanitary Materials with the Use of Probiotic Paste. Journal of Engineered Fibers and Fabrics, 15, Article ID: 155892502092221. [Google Scholar] [CrossRef] 
[38] Handalishy, I., Behery, M., Elkhouly, M., Farag, E.A. and Elsheikh, W.A. (2014) Comparative Study between Probiotic Vaginal Tampons and Oral Metronidazole in Treatment of Bacterial Vaginosis. AAMJ, 12, 185-203.
[39] Bilardi, J.E., Walker, S., Temple-Smith, M., McNair, R., Mooney-Somers, J., Bellhouse, C., Fairley, C.K., Chen, M.Y. and Bradshaw, C. (2013) The Burden of Bacterial Vaginosis: Women’s Experience of the Physical, Emotional, Sexual and Social Impact of Living with Recurrent Bacterial Vaginosis. PLoS One, 8, e74378. [Google Scholar] [CrossRef] [PubMed]
[40] Fashemi, B., Delaney, M.L., Onderdonk, A.B. and Fichorova, R.N. (2013) Effects of Feminine Hygiene Products on the Vaginal Mucosal Biome. Microbial Ecology in Health and Disease, 24, Article 19703. [Google Scholar] [CrossRef] [PubMed]
[41] Brotman, R.M., Klebanoff, M.A., Nansel, T.R., Andrews, W.W., Schwebke, J.R., Zhang, J., Yu, K.F., Zenilman, J.M. and Scharfstein, D.O. (2008) A Longitudinal Study of Vaginal Douching and Bacterial Vaginosis—A Marginal Structural Modeling Analysis. American Journal of Epidemiology, 168, 188-196. [Google Scholar] [CrossRef] [PubMed]
[42] McMillan, A., Rulisa, S., Sumarah, M., Macklaim, J.M., Renaud, J., Bisanz, J.E., Gloor, G.B. and Reid, G. (2015) A multi-platform Metabolomics Approach Identifies Highly Specific Biomarkers of Bacterial Diversity in the Vagina of Pregnant and Non-Pregnant Women. Scientific Reports, 5, Article No. 14174. [Google Scholar] [CrossRef] [PubMed]
[43] Puebla-Barragan, S., Renaud, J., Sumarah, M. and Reid, G. (2020) Malodorous Biogenic Amines in Escherichia coli-Caused Urinary Tract Infections in Women—A Metabolomics Approach. Scientific Reports, 10, Article No. 9703. [Google Scholar] [CrossRef] [PubMed]
[44] Donders, G., Bellen, G., Oerlemans, E., Claes, I., Ruban, K., Henkens, T., Kiekens, F. and Lebeer, S. (2020) The Use of 3 Selected Lactobacillary Strains in Vaginal Probiotic Gel for the Treatment of Acute Candida Vaginitis: A Proof- of-Concept Study. European Journal of Clinical Microbiology & Infectious Diseases, 39, 1551-1558. [Google Scholar] [CrossRef] [PubMed]
[45] Iwamoto, T., Suzuki, N., Tanabe, K., Takeshita, T. and Hirofuji, T. (2010) Effects of Probiotic Lactobacillus salivarius WB21 on Halitosis and Oral Health: An Open-Label Pilot Trial. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, 110, 201-208. [Google Scholar] [CrossRef] [PubMed]
[46] Masdea, L., Kulik, E., Hauser-Gerspach, I., Ramseier, A., Filippi, A., Waltimo, T., Masdea, L., Kulik, E., Hauser-Ger- spach, I., Ramseier, A., et al. (2012) Antimicrobial Activity of Streptococcus salivarius K12 on Bacteria Involved in Oral Malodour. Archives of Oral Biology, 57, 1041-1047. [Google Scholar] [CrossRef] [PubMed]
[47] Burton, J.P., Chilcott, C.N., Moore, C.J., Speiser, G. and Tagg, J.R. (2006) A Preliminary Study of the Effect of Probiotic Streptococcus salivarius K12 on Oral Malodour Parameters. Journal of Applied Microbiology, 100, 754-764. [Google Scholar] [CrossRef] [PubMed]
[48] Lebeer, S., Oerlemans, E., Claes, I., Wuyts, S., Henkens, T., Spacova, I., van den Broek, M., Tuyaerts, I., Wittouck, S., De Boeck, I., et al. (2018) Topical Cream with Live Lactobacilli Modulates the Skin Microbiome and Reduce Acne Symptoms. bioRxiv. [Google Scholar] [CrossRef] 

为你推荐